| 000 | 01128 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514020127.0 | ||
| 264 | 0 | _c20020822 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a1471-2598 | ||
| 024 | 7 |
_a10.1517/14712598.1.5.753 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurphy, M P | |
| 245 | 0 | 0 |
_aDevelopment of lipophilic cations as therapies for disorders due to mitochondrial dysfunction. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _cSep 2001 |
||
| 300 |
_a753-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCations _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 |
_aMitochondrial Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aOnium Compounds _xchemical synthesis |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 |
_aTrityl Compounds _xchemical synthesis |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 1 _gno. 5 _gp. 753-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14712598.1.5.753 _zAvailable from publisher's website |
| 999 |
_c11642243 _d11642243 |
||